发明名称 |
METHODS AND COMPOSITIONS FOR INTRATHECALLY ADMINISTERED TREATMENT OF MUCUPOLYSACCHARIDOSIS TYPE IIIA |
摘要 |
<p>The present invention provides, among other things, effective treatment for Sanfilippo Syndrome Type A (MPS IDA) based on intrathecal delivery of recombinant heparin N-Sulfatase (HNS) enzyme. In some embodiments, the present invention includes methods of treating Sanfilippo Syndrome Type A (MPS IIIA) Syndrome by intrathecal administration of a recombinant HNS enzyme at a therapeutically effective dose and an administration interval for a period sufficient to decrease glycosaminoglycan (GAG) heparan sulfate level in the cerebrospinal fluid (CSF) and/or urine relative to a control.</p> |
申请公布号 |
WO2014089487(A1) |
申请公布日期 |
2014.06.12 |
申请号 |
WO2013US73677 |
申请日期 |
2013.12.06 |
申请人 |
SHIRE HUMAN GENETIC THERAPIES, INC. |
发明人 |
HASLETT, PATRICK;BARBIER, ANN;CALIAS, PERICLES;PFEIFER, RICHARD |
分类号 |
A61K38/46;A61P43/00 |
主分类号 |
A61K38/46 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|